Member Info for shandypants2

Esh - debtors do count as revenue but as not paid are debtors (trade receivable) on cashflow - it's effectively an invoice that has not yet been paid

We have written confirmation that money is owned - should be resolved by Chinese NY - so 25/1.

Should get an update next week

price has got to 'pop' soon - all buys today

Noticed CropX are one of the companies pitching at the 2020 Our Crowd Investor Summit in Feb.
https://summit.ourcrowd.com/about-summit/

Hopefully this will lead to more orders for Starcom

poker - I did say COULD as clearly we don't know current finances (data you've quoted is now over 6 months old).

However, cash used in operating activities was £8.5m - this is a better cash burn figure to use than p&l and revenues grew by over 80%. If revenues continue to grow by say a more conservative 50% that's an extra £4m so cash burn down to c£4m assuming all others costs remain the same.
I think they had c£6m cash so that COULD be enough to get them to 2021.

Clearly market doesn't agree - think we need numbers for last 6 months to get a better idea of where we stand.

Hi Bricks, always value your posts so not have a pop but if your theory is correct then there will be more shares in issue and EUZ surely have to announce this to the market - as they do when warrants are exercised e.g. 1m warrants were exercised at x p and there are now a total of x bn shares and this figure should be used for valuation purposes.
That is why companies rarely drip feed into the market and do so in a big bang.
Also more shares would affect shareholder numbers so these would need to be announced to market - especially the Board's %.

after the late flurry of trades late yesterday I was half expecting a RNS today - quite pleased there isn't one really.

However, the buying continues so I can only see this going one way - potentially 30p before news??

Great prospects here, my only concern is the short term cash position.

ARB do trade rather than hold but as CEO has recently stated this is not real time so ARB not affected by daily fluctuations.
See his comment below..
Peter Wall: There have been moments where BCH has been more profitable—but on a weekly basis, BTC has consistently outperformed both BCH and BSV. We also don’t trade our holdings in real-time, so we aren’t affected by hourly or daily fluctuations. We are very comfortable mining BTC and plan to continue doing so going forward.

yes - now 25k at 70p. All looking a bit more positive.

possibly is being getting too much publicity but Cathal is doing what he said he would - low risk service model and getting decent long terms contracts in. The data side is also very interesting and low cost/risk.
Market value is still very low - risk v reward looks very attractive IMHO

I liked that tweet - expecting any Chinese deals to take a few weeks so an US deal would be fantastic in terms of geographical expansion and as no Parity deals are included in £4m 2020 rev target a decent one would be encouraging and show the potential of the tie up, for both companies

if you accept the offer you get 2.47 ORPH shares. Takes 2 weeks to convert so should be transferred by end of Jan.

Price is rising nicely on ORPH so hopefully worth 7p ish by end of Jan, or c17p per HVO share

yes BTC only

Q3 revenue was announced on the 8th Oct only 8 days after end of quarter. Guessing for year end some profit guidance is also required so takes a little longer but this could drop any day now.
This could be transformational for ARB
- maiden annual profit (only question is how much)
- demonstrate strategy is working
- show that mining is profitable even with low BTC value - reduces link from share price to BTC movement
- company can be properly valued e.g £3m profit at conservative 15 PE = £45m, currently valuation is c£20m

25th Jan is a Saturday so hopefully we will heard by a week on Friday. Pretty sure deal won't be a simple monetary payment else it would have been recorded in accounts at H1 that way.
We shall see.
The Biggie for me is Japanese deal for NXP002 and that could drop anytime

steady progress with new installations but it would have been good to have been given some revenue guidance for H2 2019 as this period has now completed.
In terms of headset earnings, RNS of 20/12/19 stated aquariums average was £442 per week and overall partnership average was £305 - so non aquariums are c£250 I'm guessing. As more aquariums get installed this average will increase.
Based on 400 headsets and using £350 per week average that's £7m rev a year.

yes, slow but steady buying in last few days in anticipation of the announcement. Could drop any day now, perhaps a few days delay due to xmas period, but will be in next 2 weeks at the latest

I think ST could do at least £0.5m just by being in Boots for extra 3 months and better DTC in Aus and US and extra £0.5m in peak tanning 3 months due to expanding wonder serum range and improved DTC (larger client base etc) plus also now in Tesco etc. So £1m in total.
Then C+L extra 0.1m and Prolong £0.1 based on H1 growth and assume Roots is flat (also based on H1).
We were also told that 6,500 Prolong units would be sold to a distributor in Far East. Not sure where this is, potentially delayed due to regulatory approval in the region. Guessing this could be c£0.5m if £75 per unit. Not sure if any of this is in H1, assume not as prolong increase was quite low based on really low H1 last year. If it all comes in in H2 then perhaps that's why Board seem quite confident.

If not, Growlase might now add say 0.1m as should be selling in next 6 weeks and then of course the new product launched in Feb/March. It has 9 SKU and will be sold by all 780 SD stores. Initial order could be c£250k and it will also be sold DTC (cross selling opportunities with ST customers).

So to conclude I think we should be in the right ballpark but we might need to rely on the new product to get there - FinnCap's £15.8m had zero for Growlase and new product.

If we hit £2m profit we will be trading on a PE of 6

Good spot andi - that was hidden away.

Cathal did state in recent interview that placing would be 'small' so guessing nowhere near the £10m max - maybe a couple of million IMHO.
At current share price 6.25p a share would represent minimal dilution (more shares but value of company increases by equivalent placing amount)

https://www.hardmanandco.com/research/corporate-research/taking-on-china/

Don't think above includes US deal which they state will be Q1 2020.
Another positive write up, there is not much to not like in this share - it just keeps delivering